Literature DB >> 11866229

Perinatal programming, renal development, and adult renal function.

Julie R Ingelfinger1, Lori L Woods.   

Abstract

Substantial data indicate that maternal diet during gestation, as well as perinatal events, affect organogenesis and, furthermore, may affect organ function at maturity, thus determining whether an individual is prone or resistant to a variety of health problems such as hypertension, cardiovascular disease, or renal dysfunction. This concept is called perinatal programming, or the fetal origins of adult disease (FOAD), a concept that arose after the publication of epidemiologic observations by Barker and colleagues that birth weight among apparently normal individuals studied in midlife was inversely associated with the presence of cardiovascular disease and hypertension. We now review evidence from studies in experimental animal models that have used nutritional and pharmacologic manipulation to extend epidemiologic observations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11866229     DOI: 10.1016/s0895-7061(01)02302-0

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  12 in total

1.  Maternal high-salt intake during pregnancy reprogrammed renin-angiotensin system-mediated cardiomyocyte apoptosis in the adult offspring heart.

Authors:  Juanxiu Lv; Peiwen Zhang; Yujuan Zhang; Hanzhe Kuang; Li Cao; Conglong Wu; Lin Jiang; Dawei Li; Caiping Mao; Zhice Xu
Journal:  Reprod Sci       Date:  2013-05-20       Impact factor: 3.060

2.  Maternal diabetes programs hypertension and kidney injury in offspring.

Authors:  Yun-Wen Chen; Isabelle Chenier; Stella Tran; Michael Scotcher; Shiao-Ying Chang; Shao-Ling Zhang
Journal:  Pediatr Nephrol       Date:  2010-04-27       Impact factor: 3.714

3.  Antenatal betamethasone attenuates the angiotensin-(1-7)-Mas receptor-nitric oxide axis in isolated proximal tubule cells.

Authors:  Yixin Su; Jianli Bi; Victor M Pulgar; Mark C Chappell; James C Rose
Journal:  Am J Physiol Renal Physiol       Date:  2017-02-22

4.  Long-term follow-up of extremely low birth weight infants with neonatal renal failure.

Authors:  Carolyn L Abitbol; Charles R Bauer; Brenda Montané; Jayanthi Chandar; Shahnaz Duara; Gastón Zilleruelo
Journal:  Pediatr Nephrol       Date:  2003-06-27       Impact factor: 3.714

5.  Estrogen protects against increased blood pressure in postpubertal female growth restricted offspring.

Authors:  Norma B Ojeda; Daniela Grigore; Elliott B Robertson; Barbara T Alexander
Journal:  Hypertension       Date:  2007-08-27       Impact factor: 10.190

6.  Effect of 30 per cent maternal nutrient restriction from 0.16 to 0.5 gestation on fetal baboon kidney gene expression.

Authors:  L A Cox; M J Nijland; J S Gilbert; N E Schlabritz-Loutsevitch; G B Hubbard; T J McDonald; R E Shade; P W Nathanielsz
Journal:  J Physiol       Date:  2006-03-02       Impact factor: 5.182

7.  The non-human primate kidney transcriptome in fetal development.

Authors:  Kimberly D Spradling-Reeves; Jeremy P Glenn; Kenneth J Lange; Natalia Kuhn; Jacqueline J Coalson; Mark J Nijland; Cun Li; Peter W Nathanielsz; Laura A Cox
Journal:  J Med Primatol       Date:  2018-03-30       Impact factor: 0.667

8.  Maternal diabetes modulates renal morphogenesis in offspring.

Authors:  Stella Tran; Yun-Wen Chen; Isabelle Chenier; John S D Chan; Susan Quaggin; Marie-Josée Hébert; Julie R Ingelfinger; Shao-Ling Zhang
Journal:  J Am Soc Nephrol       Date:  2008-02-27       Impact factor: 10.121

9.  Molecular basis of renal adaptation in a murine model of congenital obstructive nephropathy.

Authors:  Brian Becknell; Ashley R Carpenter; Jordan L Allen; Michael E Wilhide; Susan E Ingraham; David S Hains; Kirk M McHugh
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

Review 10.  Megabladder mouse model of congenital obstructive nephropathy: genetic etiology and renal adaptation.

Authors:  Kirk M McHugh
Journal:  Pediatr Nephrol       Date:  2013-11-26       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.